Simone Ferrero

6.8k total citations
82 papers, 1.3k citations indexed

About

Simone Ferrero is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Simone Ferrero has authored 82 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pathology and Forensic Medicine, 27 papers in Genetics and 22 papers in Oncology. Recurrent topics in Simone Ferrero's work include Lymphoma Diagnosis and Treatment (46 papers), Chronic Lymphocytic Leukemia Research (26 papers) and Viral-associated cancers and disorders (19 papers). Simone Ferrero is often cited by papers focused on Lymphoma Diagnosis and Treatment (46 papers), Chronic Lymphocytic Leukemia Research (26 papers) and Viral-associated cancers and disorders (19 papers). Simone Ferrero collaborates with scholars based in Italy, Germany and United States. Simone Ferrero's co-authors include Marco Ladetto, Daniela Drandi, Roberto Passera, Mario Boccadoro, Luigia Monitillo, Patrizia Pregno, M. Dreyling, Christiane Pott, Monika Brüggemann and Antonio Palumbo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Simone Ferrero

69 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Ferrero Italy 18 583 462 390 347 270 82 1.3k
Hyeon‐Seok Eom South Korea 24 679 1.2× 864 1.9× 530 1.4× 412 1.2× 301 1.1× 133 1.7k
Gabriella Pichert Switzerland 21 507 0.9× 541 1.2× 189 0.5× 316 0.9× 258 1.0× 46 1.5k
Blanca Sánchez‐González Spain 20 381 0.7× 304 0.7× 598 1.5× 721 2.1× 196 0.7× 70 1.5k
Nicola Di Renzo Italy 24 944 1.6× 681 1.5× 531 1.4× 329 0.9× 631 2.3× 98 1.9k
Gareth P. Gregory Australia 16 421 0.7× 495 1.1× 184 0.5× 290 0.8× 221 0.8× 74 956
Matthew Mei United States 20 391 0.7× 523 1.1× 286 0.7× 216 0.6× 292 1.1× 108 1.1k
Jan Maciej Zaucha Poland 20 428 0.7× 443 1.0× 757 1.9× 258 0.7× 374 1.4× 137 1.7k
Ferdinando Frigeri Italy 19 437 0.7× 339 0.7× 422 1.1× 211 0.6× 483 1.8× 60 1.2k
Anne Lennard United Kingdom 20 831 1.4× 561 1.2× 414 1.1× 218 0.6× 562 2.1× 51 1.6k
Mars B. van ’t Veer Netherlands 15 536 0.9× 356 0.8× 292 0.7× 181 0.5× 284 1.1× 36 1.4k

Countries citing papers authored by Simone Ferrero

Since Specialization
Citations

This map shows the geographic impact of Simone Ferrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Ferrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Ferrero more than expected).

Fields of papers citing papers by Simone Ferrero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Ferrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Ferrero. The network helps show where Simone Ferrero may publish in the future.

Co-authorship network of co-authors of Simone Ferrero

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Ferrero. A scholar is included among the top collaborators of Simone Ferrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Ferrero. Simone Ferrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Paudice, Michele, Marco Greppi, Luca Valle, et al.. (2025). The role of the Androgen Receptor (AR) in endometrial cancer aggressiveness: Correlation with other prognostic markers and therapeutic implications. A retrospective observational study. Pathology - Research and Practice. 269. 155922–155922. 3 indexed citations
3.
Sarosiek, Shayna, Andrew R. Branagan, Simone Ferrero, et al.. (2025). Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom’s Macroglobulinemia. Seminars in Hematology. 62(2). 85–89.
4.
Ferrero, Simone, Fabio Barra, Giulia Vatteroni, et al.. (2025). Safety of current strategies to manage moderate to severe pain in patients with endometriosis. Expert Opinion on Drug Safety. 25(2). 245–258.
5.
Jiang, Linmiao, Olivier Hermine, Hanneke C. Kluin‐Nelemans, et al.. (2023). Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression). Leukemia. 37(9). 1887–1894. 22 indexed citations
6.
Drandi, Daniela, et al.. (2023). MYD88 L265P Mutation Detection by ddPCR: Recommendations for Screening and Minimal Residual Disease Monitoring. Methods in molecular biology. 2621. 57–72. 2 indexed citations
7.
Dogliotti, Irene, Davide Bertuzzo, Giulia Benevolo, et al.. (2022). Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up. European Journal of Neurology. 29(12). 3611–3622. 9 indexed citations
8.
Bonfichi, Maurizio, Simone Ferrero, Giacomo Malipiero, et al.. (2018). Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program. Hematological Oncology. 36(4). 689–692. 6 indexed citations
9.
Drandi, Daniela, Simone Ferrero, & Marco Ladetto. (2018). Droplet Digital PCR for Minimal Residual Disease Detection in Mature Lymphoproliferative Disorders. Methods in molecular biology. 1768. 229–256. 20 indexed citations
10.
Pott, Christiane, Henrik Knecht, Elisa Genuardi, et al.. (2017). Standardized IGH-Based Next-Generation Sequencing for MRD Detection in Follicular Lymphoma. Blood. 130. 1491–1491. 7 indexed citations
11.
Dreyling, M., et al.. (2016). The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?. Haematologica. 101(2). 104–114. 25 indexed citations
12.
Mondello, Patrizia, Normann Steiner, Wolfgang Willenbacher, et al.. (2016). Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin’s lymphoma: evidence from a multicenter, retrospective study. Annals of Hematology. 95(7). 1107–1114. 22 indexed citations
13.
Gambella, Manuela, Paola Omedè, Stefania Oliva, et al.. (2014). In Multiple Myeloma, Minimal Residual Disease (MRD) Is an Early Predictor of Progression and Is Modulated By Maintenance Therapy with Lenalidomide. Blood. 124(21). 3394–3394. 2 indexed citations
14.
Dreyling, Martin, et al.. (2014). New Paradigms in Mantle Cell Lymphoma: Is It Time to Risk-Stratify Treatment Based on the Proliferative Signature?. Clinical Cancer Research. 20(20). 5194–5206. 16 indexed citations
15.
Ferrero, Simone & Martin Dreyling. (2013). The current therapeutic scenario for relapsed mantle cell lymphoma. Current Opinion in Oncology. 25(5). 452–462. 3 indexed citations
16.
Ferrero, Simone, Luigia Monitillo, Barbara Mantoan, et al.. (2013). Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. Annals of Hematology. 92(11). 1503–1511. 10 indexed citations
17.
Ladetto, Marco, Monika Brüggemann, Luigia Monitillo, et al.. (2013). Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. Leukemia. 28(6). 1299–1307. 218 indexed citations
18.
Lamorte, Sara, Simone Ferrero, Simona Aschero, et al.. (2011). Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells. Leukemia. 26(5). 1081–1090. 58 indexed citations
19.
Ladetto, Marco, G Pagliano, Simone Ferrero, et al.. (2010). Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma. Journal of Clinical Oncology. 28(12). 2077–2084. 181 indexed citations
20.
Bruno, Graziella, Sara Giunti, G Bargero, et al.. (2004). Sex‐differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: The Casale Monferrato Study. Diabetic Medicine. 21(8). 823–828. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026